Emyria (ASX:EMD) extended its multi-year agreement with Medibank (ASX:MPL) to fund treatment for screened and eligible customers to access the firm's treatment-resistant depression program and post-traumatic stress disorder program at Avive Health's Brisbane clinic, according to a Wednesday Australian bourse filing.
Shares of the company fell 2% in recent Wednesday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.